Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Cardiovascular Systems stock
Learn how to easily invest in Cardiovascular Systems stock.
Cardiovascular Systems Inc is a medical devices business based in the US. Cardiovascular Systems shares (CSII) are listed on the NASDAQ and all prices are listed in US Dollars. Cardiovascular Systems employs 725 staff and has a trailing 12-month revenue of around $236.2 million.
How to buy shares in Cardiovascular Systems
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CSII – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Cardiovascular Systems stock price (NASDAQ: CSII)Use our graph to track the performance of CSII stocks over time.
Cardiovascular Systems shares at a glance
|Latest market close||$12.93|
|52-week range||$12.77 - $36.97|
|50-day moving average||$15.15|
|200-day moving average||$17.61|
|Wall St. target price||$21.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.84|
Buy Cardiovascular Systems shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cardiovascular Systems stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cardiovascular Systems price performance over time
|1 week (2022-09-16)||-8.49%|
|1 month (2022-08-25)||-13.40%|
|3 months (2022-06-24)||-13.63%|
|6 months (2022-03-25)||-37.51%|
|1 year (2021-09-24)||-61.22%|
|2 years (2020-09-25)||-64.53%|
|3 years (2019-09-25)||49.49|
|5 years (2017-09-25)||27.75|
Is Cardiovascular Systems stock undervalued or overvalued?
Valuing Cardiovascular Systems stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cardiovascular Systems's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cardiovascular Systems's PEG ratio
Cardiovascular Systems's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 177.27. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cardiovascular Systems's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Cardiovascular Systems financials
|Revenue TTM||$236.2 million|
|Gross profit TTM||$172.8 million|
|Return on assets TTM||-6.63%|
|Return on equity TTM||-14.19%|
|Market capitalisation||$578.8 million|
TTM: trailing 12 months
Cardiovascular Systems share dividends
We're not expecting Cardiovascular Systems to pay a dividend over the next 12 months.
Have Cardiovascular Systems's shares ever split?
Cardiovascular Systems's shares were split on a 1:10 basis on 25 February 2009. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cardiovascular Systems shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Cardiovascular Systems shares which in turn could have impacted Cardiovascular Systems's share price.
Cardiovascular Systems share price volatility
Over the last 12 months, Cardiovascular Systems's shares have ranged in value from as little as $12.77 up to $36.97. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cardiovascular Systems's is 0.9656. This would suggest that Cardiovascular Systems's shares are less volatile than average (for this exchange).
Cardiovascular Systems overview
Cardiovascular Systems, Inc. , a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons.
Cardiovascular Systems in the news
Cardiovascular Systems (NASDAQ:CSII) Is In A Good Position To Deliver On Growth Plans
Why Is Cardiovascular Systems (CSII) Down 18.9% Since Last Earnings Report?
Frequently asked questionsWhat percentage of Cardiovascular Systems is owned by insiders or institutions?
Currently 3.923% of Cardiovascular Systems shares are held by insiders and 94.614% by institutions. How many people work for Cardiovascular Systems?
Latest data suggests 725 work at Cardiovascular Systems. When does the fiscal year end for Cardiovascular Systems?
Cardiovascular Systems's fiscal year ends in June. Where is Cardiovascular Systems based?
Cardiovascular Systems's address is: 1225 Old Highway 8 Northwest, Saint Paul, MN, United States, 55112-6416 What is Cardiovascular Systems's ISIN number?
Cardiovascular Systems's international securities identification number is: US1416191062 What is Cardiovascular Systems's CUSIP number?
Cardiovascular Systems's Committee on Uniform Securities Identification Procedures number is: 141619106
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert